Delivery Order SPE2DB20D1100-SPE2DB25FD7T4
- Not listed
- The Defense Logistics Agency awarded a $18,879.92 delivery order to AmerisourceBergen Drug Corp for Prograf 1 mg capsules (100-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Prograf (tacrolimus) is an immunosuppressant medication commonly used in transplant medicine and autoimmune disease management, representing part...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,107.15 contract is for the delivery of Prograf 1 mg capsules, a specialty medication, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Prograf 1 mg capsules, a medication used for organ transplant rejection prevention. The contract has a firm fixed price, with a ceiling value of $3,280 and a period of performance through November 12, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award, with an ID of SPE2DB22D2206|SPE2DB25FDU39, is for the delivery of Prograf 1 mg capsules to the Defense Logistics Agency (DLA). The $5,106.32 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, with no set-aside designation. The contract has an ultimate completion date of October 16, 2024 and was awarded on October 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $2,460.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Prograf 1 mg capsules, a medication used to prevent organ rejection in transplant patients. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $33,410.83, is a delivery order for the supply of 4567846606 PROGRAF 1 MG CAPSULE 100S. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $20,212.16 fixed-price contract is for the delivery of the pharmaceutical product PROGRAF 1 MG CAPSULE 100S, with a performance period ending on August 12, 2024. As a major distributor of medical supplies and pharmaceuticals, Amerisourcebergen has been awarded numerous federal contracts by various agencies, including the DLA Troop...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $8,646.10, is for the delivery of PROGRAF 5 mg capsules to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $10,326.84 and covers the delivery of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product, through September 2023. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The award, valued at $8,692.27, is for the delivery of PROGRAF 1 MG CAPSULE 100S, a prescription medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD7T4Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,657.94 by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Prograf 1 mg capsules in quantities of 100 units. This contract is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and was competitively awarded without set-aside designation. The award represents a child contract under a larger indefinite delivery contract vehicle, leveraging AmerisourceBergen's extensive pharmaceutical supply capabilities to support federal medical procurement needs. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a wide range of pharmaceutical products, medical supplies, and specialized medications to support military healthcare systems and other federal agencies. The specific delivery of Prograf, an immunosuppressant medication used in transplant patients, reflects the vendor's role in supplying critical branded pharmaceutical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 7/31/25 |